Housing and Urban Development Corporation Limited
HUDCO.BO News Today: Stay Updated with the Latest Housing and Urban Development Corporation Limited News in Real Time
Find HUDCO.BO news now at Meyka AI. Stay informed with the latest Housing and Urban Development Corporation Limited stocks updates, including price news, market analysis, and expert insights.
Deutsche Lufthansa AG (LHA.SW) Flat at CHF 7.02 Amid Sector Headwinds
LHA.SW stock trades flat at CHF 7.02 on SIX. Meyka AI rates the airline with a B grade and HOLD recommendation amid industry challenges.
DLocal Limited (DLO) Earnings Preview: Revenue Seen at $331.2M
DLocal (DLO) earnings preview: Analysts expect $0.16 EPS and $331.2M revenue on May 14. Strong growth momentum expected.
Koei Chemical (4367.T) Surges 21% on Massive Volume Spike
Koei Chemical 4367.T stock jumps 21.14% with volume spike to 153,400 shares. Tokyo specialty chemicals firm hits year high at ¥2,648.
Nifty50 Stock Market May 13: Sensex Flat Amid Crude Oil Surge
Nifty50 stock market today May 13: Sensex ends flat, Nifty50 at 23,379 down 436 points. Crude oil surge and weak rupee pressure Indian equities.
Dowa Holdings (DWMNF) Earnings Preview: EPS Seen at $4.09 on Materials Demand
Dowa Holdings earnings preview: EPS estimate $4.09, revenue $1.42B. Analysts expect strong recovery after mixed recent quarters.
Dowa Holdings (DWMNF) Earnings Preview: EPS Seen at $4.09 on Materials Demand
Dowa Holdings earnings preview: EPS estimate $4.09, revenue $1.42B. Analysts watch recycling and nonferrous metals segments.
Guangdong Adway Construction (6189.HK) Drops 10% as Construction Sector Faces Headwinds
6189.HK stock falls 10% to HK$0.072. Engineering & construction firm struggles with negative earnings and weak market sentiment on HKSE.
MediPal Holdings (MEPDF) Earnings Preview: EPS Seen at $0.24 on Pharma Demand
MediPal Holdings earnings preview: EPS estimate $0.24, revenue $5.62B expected May 14. Analyst expectations and what to watch.
NSRX Insider Trade: Rubin Eyal CFO Filing May 13, 2026
Nasus Pharma CFO Rubin Eyal files initial ownership of 40,549 share options valued at $306,550. Form 3 filing reveals executive equity stake.